Invention Grant
![[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones](/docs/US/2019-01-01/US10167293B2/abs.jpg.600x600.jpg)
- Patent Title: [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
-
Application No.: US15596383Application Date: 2017-05-16
-
Publication No.: US10167293B2Publication Date: 2019-01-01
- Inventor: Marcus Koppitz , Holger Siebeneicher , Holger Steuber , Antonius Ter Laak , Reinhard Nubbemeyer , Antje Rottmann , Horst Irlbacher , Benjamin Bader , Michaele Peters , Andrea Wagenfeld , Ildiko Terebesi
- Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Berlin
- Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee Address: DE Berlin
- Agency: Nixon & Vanderhye P.C.
- Priority: EP16171538 20160526; EP16178891 20160711
- Main IPC: C07D487/08
- IPC: C07D487/08 ; A61K31/4995 ; A61K45/06
![[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones](/abs-image/US/2019/01/01/US10167293B2/abs.jpg.150x150.jpg)
Abstract:
The present invention covers [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanone compounds of general formula (I): in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of disorders, in particular of gynecological disorders, hyperproliferative disorders, metabolic disorders, or inflammatory disorders as a sole agent or in combination with other active ingredients.
Public/Granted literature
- US20180319807A2 [8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES Public/Granted day:2018-11-08
Information query
